SRPT – sarepta therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sarepta Therapeutics (SRPT) had its price target raised by Citigroup Inc. from $9.00 to $13.00. They now have a "sell" rating on the stock.
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Sarepta Therapeutics (SRPT) had its "underperform" rating reaffirmed by Needham & Company LLC.
Assessing Sarepta Therapeutics (SRPT) Valuation After Early siRNA Trial Results Spark Share Price Rebound [Yahoo! Finance]
Sarepta (SRPT) Skyrockets 35% on Morgan Stanley PT Hike, Stellar Trial Results [Yahoo! Finance]
Form SCHEDULE 13G/A Sarepta Therapeutics, Filed by: VANGUARD GROUP INC
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Estepan Ian Michael
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Wong Ryan Ho-Yan
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Rodino-Klapac Louise
Form 4 Sarepta Therapeutics, For: Mar 12 Filed by: Mayo Stephen
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.